Harbour Investments, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$58.09 - $82.51 $60,413 - $85,810	-1,040 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $5,137 - $7,476	-88 Reduced 7.8%	1,040 $65,000
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $62 - $90	1 Added 0.09%	1,128 $93,000
Q1 2021 Aug 17, 2021	BUY	$61.35 - $90.47 $69,018 - $101,778	1,125 Added 56250.0%	1,127 $75,000
Q1 2021 May 12, 2021	BUY	$61.35 - $90.47 $122 - $180	2 New	2 $0

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.